Option chain shows key data for Polyrizon's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Polyrizon.

Polyrizon (NASDAQ:PLRZ) Stock, Option Chain

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ASNS

BROG

ELPW

HCTI

HTCR

IMNN

NAOV

NTLA

NVDA

NWTN

ORIC

PLRZ

SGBX

VEEV

Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

Feb,4,,2020,Santa,Clara, - ,Ca, - ,Usa,-

BDSX

BLMZ

CFSB

DGLY

EDBL

GELS

LDTC

Nuveen California Dividend Advantage Municipal Fund 2

PANW

PTPI

QBTS

SYTA

TUYA

WOLF

Why Toll Brothers Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

Novavax,Vaccine,For,Prevention,Of,Coronavirus,,Covid-19,,Sars-cov-2,In,Doctors

AFMD

BTOG

FBRX

GORV

HKPD

LMFA

MOVE

MYNZ

NCNA

NVAX

PNBK

QSEA

SXTC

TOPW

TSSI

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Polyrizon Ltd

Press Releases

Polyrizon Ltd. Announces $17.0 Million Private Placement

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

Polyrizon Announces Receipt of Nasdaq Delisting Notice

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Comments

Polyrizon

Polyrizon (PLRZ) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell